The global bromelain market size was valued at USD 28.3 million in 2023 and is projected to grow at a CAGR of 6.7% from 2024 to 2030. Bromelain is used across various industries, including healthcare, meat & seafood, and dietary supplements. Its increasing use in healthcare and dietary supplements is expected to drive demand, supported by growing R&D activities. The numerous health benefits of bromelain are a key factor behind its high demand in these segments, further propelling market growth.
Bromelain's role as a natural meat tenderizer and seafood processing agent drives its increased use in the food industry. Its ability to enhance texture and quality in meat and seafood makes it a valuable ingredient, contributing to the growing demand for bromelain in food processing. This trend is expected to boost the bromelain market's growth further. According to the National Center for Biotechnology Information (NCBI), bromelain is utilized for meat tenderization. Freeze-dried bromelain powder enhances the tenderness and nutritional value of tough beef by reducing shear force and boosting amino acid content. Additionally, pH levels and temperature influence the enzymatic activity and effectiveness of bromelain.
The bromelain market benefits from a consumer shift towards natural and plant-based ingredients in supplements and healthcare products. As more people seek natural alternatives, bromelain's popularity is increasing due to its plant-derived origins and associated health benefits. This rising preference is driving greater demand for bromelain across various markets. According to the New Hope Network, since 2007, the market for natural and organic products-covering foods, beverages, dietary supplements, and natural living items-has expanded from USD 97 billion to more than USD 300 billion. This growth reflects a compound annual growth rate (CAGR) of 6.67%.
The growing awareness of Bromelain's health benefits significantly boosts its growth, especially in emerging markets. Consumers and industries increasingly recognize its potential for anti-inflammatory and digestive health, driving its adoption. This heightened awareness is propelling demand across various sectors. For instance,
The meat & seafood segment dominated the market and accounted for a share of 45.9% in 2023. The global rise in meat and seafood consumption is driving the use of bromelain to tenderize these foods and enhance their palatability. This proteolytic enzyme breaks down proteins in tough meats, making them more tender and enjoyable for consumers. By hydrolyzing the proteins, bromelain improves the texture and tenderness of meat.
The dietary supplements segment is expected to grow at the fastest CAGR of 7.0% over the forecast period. This trend is driven by growing health awareness and increased consumer purchasing power, particularly in developing economies. Many of these markets were previously underserved, and companies are actively running awareness campaigns to highlight Bromelain's benefits and boost demand. For instance, in January 2023, MediNiche, Inc. introduced Bone-Tite, a supplement designed to support osseointegration for dental implant patients. The formula features a "bone-building complex" that includes manganese, potassium, magnesium, copper, calcium, zinc, vitamins C, D-3, and K-1. In addition, it contains bone-strengthening agents such as bromelain, L-lysine, boron, and ipriflavone.
North America bromelain market dominated the market with 28.9% share in 2023. Rising awareness of bromelain's benefits and increased consumer purchasing power in the region drive its demand. Additionally, the growing needs in the healthcare and meat and seafood industries contribute to the product's increased popularity. According to the U.S. Bureau of Labor Statistics, in North America, consumer spending reached USD 18,678.07 billion, marking a 9.01% rise from 2021. The most significant expenditure increase was in cash contributions, up by 14.1%, followed by food at 12.7%, personal care products and services at 12.3%, and transportation at 12.2%. The only major category to see a decrease was entertainment, which fell by 3.1%.
The U.S. bromelain market dominated the North American market with a share of 91.1% in 2023 due to the rise in healthcare trends, significantly driving the market. Increasing consumer interest in natural and alternative therapies has led to a surge in the use of bromelain in dietary supplements and health products. This growing demand reflects a broader shift towards integrating natural remedies into health and wellness routines.
Europe bromelain market was identified as a lucrative region in 2023. The European bromelain market benefits from its application in the cosmetics industry, where its exfoliating and skin-soothing properties cater to consumers’ demand for innovative beauty solutions. This trend drives market growth as more people seek effective and natural ingredients for their skincare routines. For instance, in 2023, the European cosmetics and personal care market reached a substantial value of USD 104.79 billion at retail sales prices, establishing Europe as a leading global market in this sector. The largest markets within Europe include Germany, with sales amounting to USD 17.36 billion, followed by France at USD 14.95 billion, Italy at USD 13.64 billion, the UK at USD 12.01 billion, Spain at USD 11.35 billion, and Poland at USD 5.68 billion.
Germany bromelain market held a substantial market share in 2023 owing to the rising demand for functional foods that provide extra health benefits fuels the market. As consumers seek foods with added health advantages, bromelain is increasingly incorporated into diverse products.
Asia Pacific bromelain market is expected to grow at the fastest CAGR of 7.5% over the forecast period. Asia Pacific is the world's leading pineapple producer, with major bromelain manufacturing facilities in the region. The area's optimal land and temperature conditions are ideal for cultivating pineapples, ensuring a steady supply of high-quality raw materials. This consistent availability of raw materials supports the robust production of bromelain in the region. According to the Vietnam Agriculture, Asia leads the world in pineapple production and consumption, driven by substantial local demand and the largest cultivation area. In 2021, Indonesia led the region in production with 2.88 million metric tons, with the Philippines coming in a close second with 2.86 million metric tons and India following with 1.7 million metric tons.
Thailand bromelain market is expected to grow rapidly in the coming years due to the significant expansion of the healthcare and wellness industry driving the market. As the sector grows, bromelain is increasingly used in dietary supplements and natural remedies due to its recognized health benefits. This trend reflects a broader shift towards integrating natural and effective ingredients into health and wellness products, fueling greater demand for bromelain in the Thai market.
China bromelain market held a substantial market share in 2023 owing to the growing elderly population is a key driver of the market. As more seniors seek natural remedies for digestive and anti-inflammatory issues, the demand for bromelain, known for its beneficial health properties, increases. This demographic shift towards natural health solutions fuels greater interest and consumption of bromelain products in the Chinese market. According to the World Health Organization (WHO), China is experiencing one of the fastest-growing aging populations globally. By 2040, 28% of the population is projected to be over 60 years old, driven by increased life expectancy and declining fertility rates.
Some of the key companies in the bromelain market include Hong Mao Biochemicals Co., Ltd., ENZYBEL GROUP, Great Food Group of Companies, Advanced Enzyme Technologies, Guangxi Nanning Javely Biological Products Co. Ltd., Nanning Pangbo Biological Engineering Co., Ltd., Nanning Doing Higher Bio-Tech Co. Ltd., Changsha Natureway Co., Ltd., Biozym Gesellschaft für Enzymtechnologie mbH, and URSAPHARM Arzneimittel GmbH. Organizations are focusing on increasing customer base to gain a competitive edge in the industry. Therefore, key players are taking several strategic initiatives, such as mergers and acquisitions, and partnerships with other major companies.
Hong Mao Biochemicals Co., Ltd. specializes in producing bromelain, an enzyme derived from pineapples known for its digestive and anti-inflammatory properties. They focus on high-quality, purified bromelain for various pharmaceutical, dietary supplements, and food processing applications. Their advanced extraction and production technologies ensure the enzyme's efficacy and safety.
ENZYBEL GROUP is a provider of bromelain, a proteolytic enzyme extracted from pineapple stems, renowned for its extensive applications in pharmaceuticals, dietary supplements, and industrial processes
The following are the leading companies in the bromelain market. These companies collectively hold the largest market share and dictate industry trends.
In January 2023, Sun Pharma acquired three brands from Aksigen Hospital Care, a research-focused healthcare company with over 20 years of experience. The acquired brands are Phlogam (Bromelain 90 mg, Rutoside Trihydrate 100 mg, Trypsin BP 48 mg), Disperzyme-CD (Bromelain 90 mg, Rutoside Trihydrate 100 mg, Trypsin BP 48 mg), and Disperzyme (Bromelain 180 mg, Rutoside Trihydrate 200 mg, Trypsin BP 96 mg.)
In October 2020, Giellepi S.p.A. introduced Bromeyal, its proprietary bromelain ingredient. This plant-derived enzyme delivers all the health benefits of bromelain without the need for enteric-coating technologies.
Report Attribute |
Details |
Market size value in 2024 |
USD 30.5 million |
Revenue forecast in 2030 |
USD 45.1 million |
Growth rate |
CAGR of 6.7% from 2024 to 2030 |
Base year for estimation |
2023 |
Historical data |
2018 - 2022 |
Forecast period |
2024 - 2030 |
Quantitative units |
Revenue in USD million, volume in tons, and CAGR from 2024 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Application, region |
Regional scope |
North America, Europe, Asia Pacific, Central & South America, MEA |
Country scope |
U.S., Germany, China, India, Philippines, Thailand, Brazil, South Africa |
Key companies profiled |
Hong Mao Biochemicals Co., Ltd.; ENZYBEL GROUP; Great Food Group of Companies; Advanced Enzyme Technologies; Guangxi Nanning Javely Biological Products Co. Ltd.; Nanning Pangbo Biological Engineering Co., Ltd.; Nanning Doing Higher Bio-Tech Co. Ltd.; Changsha Natureway Co., Ltd.; Biozym Gesellschaft für Enzymtechnologie mbH; URSAPHARM Arzneimittel GmbH |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global bromelain market report based on application, and region.
Application Outlook (Volume, Tons; Revenue, USD Million, 2018 - 2030)
Healthcare
Meat & Seafood
Dietary Supplements
Others
Regional Outlook (Volume, Tons; Revenue, USD Million, 2018 - 2030)
North America
U.S.
Europe
UK
Germany
Asia Pacific
China
India
Philippines
Thailand
Central & South America
Brazil
Middle East and Africa (MEA)
South Africa
b. The global bromelain market size was estimated at USD 28.3 million in 2023 and is expected to reach USD 30.5 million in 2024.
b. The global bromelain market is expected to grow at a compound annual growth rate of 6.7% from 2024 to 2030 to reach USD 45.1 million by 2030.
b. North America dominated the bromelain market with a share of 28.9% in 2023. This is attributable to growth in healthcare, meat & seafood, dietary supplements, bakery, cosmetics, and beverage sectors.
b. Some key players operating in the bromelain market include Enzybel International SA, Enzyme Technology (PTY) Ltd, Hong Mao Biochemicals Co., Ltd, Great Food Group of Companies, Nanning Doing-Higher Bio-Tech Co., Ltd, Biozym Gesellschaft für Enzymtechnologie mbH, Cn Lab Nutrition, Arisun ChemPharm, Changsha Natureway Co., Ltd.
b. Key factors that are driving the bromelain market growth include a surge in R&D towards the use of bromelain to cure cancer, HIV aids, and inflammatory diseases like asthma, coeliac disease, hepatitis, glomerulonephritis, and autoimmune diseases.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."